The NASA Life Sciences Portal (NLSP) is the data platform for accessing NASA's Life Sciences Data Archive (LSDA). The LSDA is an active archive that provides information and data from 1961 (Mercury Project) through current flight and flight analog studies (International Space Station, Shuttle, bed rest studies, etc.) involving human, plant and animal subjects. Alternative contact: Jessica Keune (jessica.a.keune@nasa.gov)

Snapshot img

Life Science Software Market Size 2024-2028

The life science software market size is forecast to increase by USD 4.56 billion at a CAGR of 8.58% between 2023 and 2028.

The market is experiencing significant growth, driven by several key trends and factors. One major trend is the increasing focus on storing and managing large volumes of patient data, fueled by the need for personalized and precision medicine. Another trend is the emergence of advanced technologies, such as artificial intelligence and machine learning, which are transforming the way data is analyzed and utilized In the life sciences industry. Additionally, data security and privacy concerns have become a top priority, with stringent regulations and compliance requirements driving the adoption of secure software solutions. These factors, among others, are expected to drive the growth of the market In the coming years.

What will be the Size of the Life Science Software Market During the Forecast Period?

Request Free Sample

The market encompasses a range of applications designed to support various aspects of life sciences, including patient data management, pharma-related data analysis, workflows in life sciences laboratories, inventory management, and supply chain optimization. Enterprises In the life sciences sector, including biology, anatomy, health sciences, medical sciences, pharmaceutics, biopharmaceuticals, medical technology, generics, and clinical care industries, rely on these software solutions to streamline operations and enhance productivity. Life science software enables the handling and analysis of large volumes of data, from drug identification to sales efficiency. Advanced AI models, such as Generative AI and Variational Autoencoders (VAEs), are increasingly being integrated into these systems to provide hyper-customized content for marketing teams and improve workflows.
The integration of AI in life science software is expected to revolutionize the industry by providing accurate and efficient solutions for data analysis and inventory management. Overall, the market for life science software is expected to grow significantly In the coming years, driven by the increasing demand for advanced tools to support research and development In the life sciences sector.

How is this Life Science Software Industry segmented and which is the largest segment?

The life science software industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Deployment

  Cloud-based
  On-premises


End-user

  Pharmaceutical
  Biotechnology
  Others


Geography

  North America

    US


  Europe

    Germany
    UK
    France


  APAC

    Japan


  South America



  Middle East and Africa

By Deployment Insights

The cloud-based segment is estimated to witness significant growth during the forecast period.

Life science software plays a pivotal role in managing patient data and pharma-related data in life sciences laboratories and enterprises. Workflows In these organizations heavily rely on life science tools for inventory management, supply chain, and data analytics. The integration of generative AI, such as AI models and variational autoencoders (VAEs), enables the discovery of drug-like molecules and identification of target proteins. Synthetic gene orders and synthetic biology also benefit from data-driven methodologies, which amplify missing data through advanced analytics. Cloud and edge computing facilitate the secure storage and processing of genome sequence datasets and sensitive information. Marketing teams leverage marketing automation solutions, including automated email tracking and dashboarding, to create hyper-customized content for sales efficiency.

Data breaches and insider risks necessitate robust security measures, with cloud deployment providing scalability and flexibility. Medical research centers can make informed business decisions through the assimilation of data from various sources, enabling digital marketing strategies and automated marketing campaigns.

Get a glance at the Life Science Software Industry report of share of various segments Request Free Sample

The Cloud-based segment was valued at USD 4.60 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 46% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The market in North America is driven by the increasing demand for enhanced security, easy access to data, and efficient pati

Success.ai’s Company Funding Data for Pharmaceuticals, Biotech & Life Sciences Leaders Globally provides a comprehensive dataset tailored for businesses and investors looking to connect with decision-makers and innovators in these industries. Covering executives, research directors, and investment leads, this dataset includes verified contact details, funding insights, and firmographic data from 70 million businesses worldwide.

With access to over 700 million verified global profiles, Success.ai ensures your outreach, market research, and investment strategies are powered by accurate, continuously updated, and AI-validated data. Supported by our Best Price Guarantee, this solution is indispensable for navigating the fast-evolving biotech, life sciences, and pharmaceutical sectors.

Why Choose Success.ai’s Company Funding Data?

1. Verified Funding and Contact Data for Precision Engagement

   • Access verified work emails, phone numbers, and LinkedIn profiles of executives, investors, and key decision-makers.
   • AI-driven validation ensures 99% accuracy, improving outreach effectiveness and minimizing wasted effort.

2. Comprehensive Global Coverage of Key Players

   • Includes profiles from global pharmaceutical companies, biotech startups, and life sciences research organizations.
   • Gain insights into funding rounds, investment trends, and research initiatives in North America, Europe, and Asia-Pacific.

3. Continuously Updated Datasets

   • Real-time updates capture changes in leadership, funding milestones, and business expansions.
   • Stay aligned with evolving market conditions and capitalize on emerging opportunities.

4. Ethical and Compliant

   • Fully adheres to GDPR, CCPA, and other global data privacy regulations, ensuring responsible and lawful data usage.

Data Highlights:

• 700M+ Verified Global Profiles: Engage with professionals and leaders in pharmaceuticals, biotech, and life sciences worldwide.
• 70M Business Profiles: Access detailed firmographic data, including funding histories, revenue ranges, and geographic footprints.
• Funding Insights: Gain visibility into venture capital rounds, private equity investments, and R&D funding allocations.
• Leadership Contacts: Connect with CEOs, CFOs, and research directors driving innovation and business growth.

Key Features of the Dataset:

1. Comprehensive Funding and Leadership Profiles

   • Identify and connect with executives managing investments, R&D initiatives, and financial strategies.
   • Target professionals responsible for securing funding, managing partnerships, and overseeing product development.

2. Advanced Filters for Precision Targeting

   • Filter companies by funding stage (seed, Series A, IPO), industry focus (pharmaceuticals, biotech, life sciences), or geographic location.
   • Tailor campaigns to align with specific business goals, such as securing partnerships or exploring investment opportunities.

3. Global Trends and Investment Insights

   • Leverage data on funding trends, market opportunities, and breakthrough innovations across key regions.
   • Use these insights to refine investment strategies, identify potential partners, or shape product development.

4. AI-Driven Enrichment

   • Profiles enriched with actionable data allow for personalized messaging, highlight unique value propositions, and improve engagement outcomes.

Strategic Use Cases:

1. Investment and Venture Development

   • Identify biotech startups and life sciences companies seeking funding, and build relationships with key stakeholders.
   • Present funding opportunities, venture capital solutions, or strategic investment proposals to decision-makers.

2. Market Research and Competitive Analysis

   • Analyze global funding trends, emerging technologies, and market needs to refine business strategies.
   • Benchmark against competitors to identify growth opportunities and innovative solutions.

3. Sales and Partnership Development

   • Engage with pharmaceutical and biotech companies to offer financial tools, R&D solutions, or investment partnerships.
   • Build long-term relationships with companies exploring product commercialization or market expansion.

4. Recruitment and Talent Acquisition

   • Target HR professionals and hiring managers seeking experienced candidates for roles in R&D, finance, or investment management.
   • Provide workforce optimization platforms or recruitment solutions tailored to the biotech and life sciences sectors.

Why Choose Success.ai?

1. Best Price Guarantee

   • Access premium-quality company funding data at competitive prices, ensuring strong ROI for your marketing, research, and investment initiatives.

2. Seamless Integration

   • Integrate verified funding and contact data into CRM systems, analytics tools, or investment platforms via APIs or downloadable formats, streamlining ...

This annual report includes charts on the UK life science sector, and how it compares to other countries. Areas covered include:

UK industry research and development regulatory environment clinical research

The size and share of the market is categorized based on Type (Cloud-based, On-premise) and Application (Research & Academic Institutes, Pharma & Biotech Companies, CROs) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

In the SHARP-ID, environmental impact assessment was based on attributional life cycle analyses using environmental indicators greenhouse gas emission (GHGE) and land use (LU). Life cycle inventory data of 182 primary products were combined with data on production, trade and transport, and adjusted for consumption amount using conversions factors for production, edible portion, cooking losses and gains, and for food losses and waste in order to derive estimates of GHGE and LU for the foods as eaten. Towards a public database for environmental sustainability SHARP-ID Towards a public database for environmental sustainability

41374 Global exporters importers export import shipment records of Life science with prices, volume & current Buyer's suppliers relationships based on actual Global export trade database.

Comprehensive dataset of insider trading activities for ACHIEVE LIFE SCIENCES, INC., including Form 4 filings and transaction visualizations.

Global HPC, Data Analysis, Storage And Management in Life Sciences Market to grow from US$ 36.29 Bn in 2023 to US$ 177.02 Bn by 2032, at CAGR of 17.2%.

Snapshot img

Life Sciences Analytics Market Size 2024-2028

The life sciences analytics market size is forecast to increase by USD 7.83 billion at a CAGR of 12.02% between 2023 and 2028. The market is experiencing robust growth, fueled by the increasing integration of big data with healthcare analytics, the rising adoption of Electronic Health Records (EHRs), and the growing emphasis on personalized medicine. These trends are driving demand for innovative solutions, advancements in technology, and changing consumer preferences. The market's expansion is also influenced by a transition towards more efficient systems, better accessibility, and higher industry standards. Companies in this sector are responding by prioritizing sustainability and operational efficiency to maintain a competitive edge. As the market evolves, these dynamics continue to shape its direction, supporting long-term growth. The demand for advanced solutions is expanding the market's scope, ensuring its continued evolution. The integration of big data with healthcare analytics enables more accurate diagnoses, improved patient outcomes, and enhanced population health management. The increasing adoption of EHRs streamlines the healthcare delivery process, enhancing patient care and reducing administrative costs.

What will be the size of the market during the forecast period?

Request Free Sample

Life Sciences Analytics Market Segmentation

The life sciences analytics market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

Deployment

  Cloud
  On-premises


End-user

  Pharmaceutical companies
  Biotechnology companies
  Others


Geography

  North America

    US


  Europe

    Germany
    UK
    France


  Asia

    Japan


  Rest of World (ROW)

Which is the largest segment driving market growth?

The cloud segment is estimated to witness significant growth during the forecast period.

Cloud-based life sciences analytics refers to the use of cloud technology to process and analyze data In the healthcare and life sciences industry. This approach eliminates the need for additional software installation, as data is maintained at the company's data center. End-users can access the data on a subscription basis, paying a monthly fee that covers maintenance and system upgrades. The biotech and pharmaceutical sectors, which require significant research and development, are major adopters of cloud solutions. Big data plays a crucial role in this domain, particularly In the analysis of chronic disorders, medical imaging, risk management, supply chain management, and preclinical trials.

Additionally, cloud-based analytics facilitates descriptive, predictive, diagnostic, discovery, and prescriptive analytics, as well as pharmacovigilance and clinical trial designing. The services segment includes outsourcing services, digital literacy, and artificial intelligence algorithms. The life sciences industry encompasses biotechnology companies, medical device companies, research centers, third-party administrators, and healthcare providers. Cloud-based analytics enhances clinical outcomes, financial outcomes, and operational outcomes, while also improving patient care experience, personalized medication, and human genome combinations. Electronic health records, artificial intelligence, and healthcare systems are essential components of this infrastructure. Non-communicable diseases and the global geriatric population further underscore the importance of cloud-based analytics In the healthcare sector.

Get a glance at the market share of various regions. Download the PDF Sample

The Cloud segment was valued at USD 4.44 billion in 2018 and showed a gradual increase during the forecast period.

Which region is leading the market?

North America is estimated to contribute 36% to the growth of the global market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.The market in North America is driven by the demand for enhanced security, efficient data access, and effective patient information management. The US and Canada are major contributors to this market due to their early adoption of advanced technologies, such as machine learning, predictive analytics, and quantum computing. The high penetration rate of technology and the maturity of these economies have led to extensive digitalization In the life sciences sector, generating a substantial volume of data. Key companies in this market include SAS Institute, Oracle, and Veeva Systems. The use of big data and advanced analytics techniques, such as descriptive, predictive,

9849 Global export shipment records of Life Science with prices, volume & current Buyer's suppliers relationships based on actual Global export trade database.

Explore the Data Monetization Solutions For Life Science Companies Market trends! Covers key players, growth rate 19.5% CAGR, market size $1.02 Billion, and forecasts to 2033. Get insights now!

Life Science Database Archive is an archive of databases generated by life scientists in Japan as national public goods. This archive contains databases deposited from research institutions with metadata in a unified format to search datasets easily. Users can search for datasets across metadata and databases and perform BLAST search, as well as download the whole datasets with clear terms of use.

Life Sciences Data Mining and Visualization Software Market Analysis: The global Life Sciences Data Mining and Visualization Software market is expected to reach USD XXX million by 2033, expanding at a CAGR of XX% over the forecast period (2025-2033). The surge in the volume and complexity of data in the life sciences industry, particularly in genomics, proteomics, and other omics fields, is driving the demand for specialized data mining and visualization tools. These tools enable researchers and scientists to analyze, interpret, and visualize complex datasets, which aids in drug discovery, biomarker identification, and disease diagnosis. Key Market Trends and Drivers: The growth of the Life Sciences Data Mining and Visualization Software market is attributed to several trends, including the increasing adoption of cloud-based solutions, the rise of artificial intelligence (AI) and machine learning (ML) in life sciences research, and the growing awareness of the importance of data visualization in decision-making. Additionally, the increasing demand for personalized medicine and the need to improve drug development efficiency are also driving the demand for these software solutions. The key players in the market include Accenture, Cognizant, Dundas Data Visualization Inc., IBM Corporation, and Microsoft Corporation, among others.

According to Cognitive Market Research, the global life science software market size is USD 16.2 billion in 2023 and will enhance at a compound annual growth rate (CAGR) of 13.50% from 2023 to 2030.

The global life science software market will expand significantly by 13.50% CAGR between 2023 and 2030.
The demand for life science software is rising due to technological advancement.
Demand for marketing remains higher in the life science software market.
The on-premises category held the highest life science software market revenue share in 2023.
North America will continue to lead, whereas the European life science software market will experience the most substantial growth until 2030

Continuous Technological Advancements to Provide Viable Market Output

The life science software market is thriving due to continuous technological advancements. Innovations such as advanced analytics, artificial intelligence, and cloud computing are reshaping the industry. These technologies enhance research, drug development, and clinical trials, fostering efficiency and precision. The market's growth is fueled by a relentless pursuit of cutting-edge solutions, elevating the capabilities of life science professionals and organizations to drive breakthroughs in healthcare and biotechnology.

For instance, in April 2021, IQVIA established Connected Intelligence for customers to utilize analytical solutions to discover data-driven insights and help effective decision-making. IQVIA incorporated its expertise in healthcare analytics with creative technologies to provide Connected Intelligence solutions.

Increasing Usage of Analytics for Sales and Marketing Applications to Propel Market Growth

The life science software market is experiencing growth due to an escalating adoption of analytics in sales and marketing applications. Companies increasingly leverage data analytics to enhance decision-making processes, target specific customer segments, and optimize marketing strategies. This trend is driven by the desire for more efficient and targeted approaches, leading to improved customer engagement and increased sales. As analytics continue to play a pivotal role in business strategies, the life science software market is poised for sustained expansion. For instance, in February 2021, Nemours Children's Health System accepted analytical help from Oracle to adopt cloud business applications to be deployed in different business departments of the institution.

Market Dynamics For The Life Science Software Market

Data Privacy and Security Concerns to Restrict Market Growth

The life science software market faces significant restraints due to escalating data privacy and security concerns. As sensitive biological and patient data become increasingly digitalized, ensuring robust protection against unauthorized access and data breaches becomes paramount. Stringent regulatory requirements and the potential for reputational damage in case of security lapses contribute to a challenging landscape. Consequently, industry players must invest in advanced cybersecurity measures to alleviate concerns and foster trust in adopting life science software solutions.

Impact of COVID–19 on the Life Science Software Market

The life science software market witnessed significant growth accelerated by the COVID-19 pandemic. The increased demand for solutions supporting drug discovery, vaccine development, and data management in response to the global health crisis drove market expansion. As life sciences organizations prioritized digital transformation, the software market adapted to meet these evolving needs. This adoption surge addressed pandemic-related challenges and fostered long-term advancements in life science research and development. What is Life Science Software?

The life science software market is burgeoning due to rapid advancements in precision medicine. Innovations in data analytics, genomic sequencing, and clinical informatics are transforming healthcare. Precision medicine tailors treatments based on individual genetic, environmental, and lifestyle factors, optimizing outcomes. This paradigm shift drives demand for sophisticated software solutions, propelling the life science software market forward as a key enabler of personalized and effective healthcare strategies.

For instance, in March 2022, Wipro Limited (India) partnered with Pandorum (India). This partner...

Global HPC Data Analysis Storage And Management in Life Sciences market size 2025 was XX Million. HPC Data Analysis Storage And Management in Life Sciences Industry compound annual growth rate (CAGR) will be XX% from 2025 till 2033.

Life Sciences Tools Market size was valued at USD 63.8 Billion in 2024 and is projected to reach USD 112.99 Billion by 2031, growing at a CAGR of 8.17% from 2024 to 2031.

Life Sciences Tools Market Drivers

Advancements in Life Science Research: Continuous progress in fields like genomics, proteomics, and cell biology drives the demand for more sophisticated tools and technologies.
Increasing R&D Spending: Growing investments in pharmaceutical and biotechnology R&D by both public and private sectors fuel the demand for advanced life science tools.
Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases like cancer, diabetes, and cardiovascular diseases necessitates advanced diagnostic and therapeutic tools.
Growing Focus on Personalized Medicine: The shift towards personalized medicine, which involves tailoring treatments to individual patients based on their genetic makeup, is driving demand for tools used in genetic testing and analysis.

Life sciences doctorate recipients of Rhode Island slumped by 9.72% from 72 number in 2018 to 65 number in 2019. Since the 7.94% surge in 2017, life sciences doctorate recipients declined by 4.41% in 2019.

This dataset is comprised of a collection of example DMPs from a wide array of fields; obtained from a number of different sources outlined below. Data included/extracted from the examples include the discipline and field of study, author, institutional affiliation and funding information, location, date created, title, research and data-type, description of project, link to the DMP, and where possible external links to related publications or grant pages. This CSV document serves as the content for a McMaster Data Management Plan (DMP) Database as part of the Research Data Management (RDM) Services website, located at https://u.mcmaster.ca/dmps. Other universities and organizations are encouraged to link to the DMP Database or use this dataset as the content for their own DMP Database. This dataset will be updated regularly to include new additions and will be versioned as such. We are gathering submissions at https://u.mcmaster.ca/submit-a-dmp to continue to expand the collection.

Life Sciences Data Mining and Visualization Software Market Analysis

The Life Sciences Data Mining and Visualizat...